Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antimicrobial Effect of Calcium Silicate and Pectin as Intracanal Medications
NCT07423663Phase 1Active, not recruiting
- Sponsor
- Suez Canal University
- Start
- Sep 2024
- Primary completion
- Mar 2026
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 1, randomised trial of TheraCal and pectin in apical periodontitis (AP) (3 arms), sponsored by Suez Canal University. Primary endpoint: Microbiome Changes at 2 weeks. Started Sep 2024; status: active, not recruiting.
02
Drugs
TheraCalpectin
03
Conditions
apical periodontitis (AP)
Beyond the preview
Go deeper on NCT07423663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07423663.